A Phase I Study to Evaluate the Safety and Pharmacokinetics of TQB3824 in Subjects With Advanced Cancer
TQB3824 blocks function of a specific protein called Cell Division Cycle 7 (CDC7) kinase in the human body, which plays important roles in the maintenance of DNA replication forks and DNA damage response pathways. This study will evaluate the safety, tolerability and pharmacokinetics of TQB3824.
TQB3824在晚期恶性肿瘤受试者中的安全性和药代动力学I期临床试验
主要目的:评估 TQB3824 在晚期恶性肿瘤受试者中的安全性。
次要目的:评估TQB3824在晚期恶性肿瘤受试中的药代动力学(PK)特征、初步有效性; 评估TQB3824在晚期恶性肿瘤受试中作用机制相关的潜在生物标志物的研究。
100 项与 TQB-3824 相关的专利(医药)